New Directions in Lung Cancer Care - Anita Kaul, MD - UCLA Health
University of California, Los Angeles via YouTube
-
27
-
- Write review
Overview
Syllabus
Intro
Lung Cancer Incidence
Chemotherapy
Stage 3 Lung Cancer
New Directions in Lung Cancer
Stage 4 Lung Cancer
New chemotherapies
Avastin
Maintenance treatment
Angiogenesis switch
Antibodies
Targeted drugs
Avastin and Cetuximab
Gene pathways
Types of CAN services
ROS1 mutation
Other mutations
Alch mutation
What is a targeted drug
Lung cancer trials
Fine needle aspiration
Collaboration
Targeted Therapy
Tumor Markers
PT Skin
Communitybased practice
Clinical trials of targeted drugs
Biopsy options
Rise in nonsmokers lung cancer
Intervention for nonsmokers
Screening for lung cancer
Clinical trials for lung cancer
How are patients volunteer tumor pieces collected
Taught by
UCLA Health
Tags
Reviews
5.0 rating, based on 1 Class Central review
-
Overall, New Directions in Lung Cancer Care is a highly valuable resource for anyone involved in treating or managing patients with lung cancer. Dr. Kaul’s expertise and the course’s comprehensive, up-to-date content make it an indispensable learning experience. It’s both a great introduction for those new to the field and an excellent update for those looking to stay current with the latest in lung cancer treatment. I highly recommend it for clinicians who want to improve patient outcomes with the most advanced and evidence-based approaches available.